Nathalie Weitemeyer

Dr. Nathalie Weitemeyer is the Director of Life Science and Senior Investment Manager at Bayern Kapital, based in Bavaria, Germany. She has been financing early-stage startups with the firm since 2001, deploying capital from a fund that manages over 1.3 billion euros and supports more than 115 active portfolio companies. Her investment strategy targets seed through Series B rounds in the biotechnology, health information technology, and material science sectors, typically writing initial cheques ranging from $100,000 to $5 million, with follow-on investments reaching up to 50 million euros per company. Leveraging her involvement with regional institutions like ChemieCluster Bayern, she has guided numerous life sciences and medical technology ventures through complex clinical development phases. Trained as a chemist with a postgraduate degree in business administration, Weitemeyer currently focuses on scaling high-growth healthcare and enterprise software companies.